BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 35083279)

  • 1. Matrin3: Disorder and ALS Pathogenesis.
    Salem A; Wilson CJ; Rutledge BS; Dilliott A; Farhan S; Choy WY; Duennwald ML
    Front Mol Biosci; 2021; 8():794646. PubMed ID: 35083279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
    Yamaguchi A; Takanashi K
    Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prion-like nature of amyotrophic lateral sclerosis.
    McAlary L; Yerbury JJ; Cashman NR
    Prog Mol Biol Transl Sci; 2020; 175():261-296. PubMed ID: 32958236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
    Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
    J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis.
    McAlary L; Plotkin SS; Yerbury JJ; Cashman NR
    Front Mol Neurosci; 2019; 12():262. PubMed ID: 31736708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
    Prasad A; Bharathi V; Sivalingam V; Girdhar A; Patel BK
    Front Mol Neurosci; 2019; 12():25. PubMed ID: 30837838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis.
    Nishimoto Y; Nakagawa S; Hirose T; Okano HJ; Takao M; Shibata S; Suyama S; Kuwako K; Imai T; Murayama S; Suzuki N; Okano H
    Mol Brain; 2013 Jul; 6():31. PubMed ID: 23835137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.
    Pham J; Keon M; Brennan S; Saksena N
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
    Shang Y; Huang EJ
    Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A robust TDP-43 knock-in mouse model of ALS.
    Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DnaJC7 in Amyotrophic Lateral Sclerosis.
    Dilliott AA; Andary CM; Stoltz M; Petropavlovskiy AA; Farhan SMK; Duennwald ML
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
    Kim HC; Zhang Y; King PH; Lu L
    J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
    Smethurst P; Sidle KC; Hardy J
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of phase separation and amyloidosis of ALS/FTD-linked FUS and TDP-43.
    Song J
    Aging Dis; 2023 Nov; ():. PubMed ID: 38029395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
    Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
    Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.
    Bastow EL; Gourlay CW; Tuite MF
    Biochem Soc Trans; 2011 Oct; 39(5):1482-7. PubMed ID: 21936838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.